Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 561-570 of 603 for hematology

Edit search filters
  1. Symptom Assessment of Patients following Percutaneous Transesophageal Gastrostomy Tube Placement

    Scottsdale/Phoenix, AZ

  2. Risk Factors Associated with Clustered Plasma Cell Dyscrasias in Minnesota

    Rochester, MN

  3. A Study To Determine Molecular Mechanisms In Breast Implant Associated-Anaplastic Large Cell Lymphoma

    Jacksonville, FL

  4. A Study to Assess Anxiety Associated with Outpatient Visits in Pediatric Oncology Patients

    Rochester, MN

  5. Assessment Of The Mechanical Properties Of Lung Parenchyma Using Magnetic Resonance Elastography In Lung Cancer

    Rochester, MN

  6. Cytotoxic Activity of Lenalidomide in Combination with the Bispecific CD30/CD16a Therapeutic Monoclonal Antibody, AFM13

    Jacksonville, FL

  7. A Study To Explore Quality Of Life According To Treatment Plan For Patients With Multiple Myeloma Following Autologous Stem Cell Transplant

    Rochester, MN

  8. Mayo Clinic Cancer Center Neuro-Oncology Program Registry And Biobank For The Study Of Nervous System Tumors

    Rochester, MN

  9. A Study To Assess Financial Burden And Its Impact On Quality Of Life In Patients With Plasma Cell Disorders

    Rochester, MN

  10. Manufacturing Outcomes With Patient Factors From Multiple Myeloma Patients Prescribed Ciltacabtagene Autoleucel

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer